³Ô¹ÏÍøÕ¾

Latest

Latest biotech News | Page 11

  • Latest biotech news stories and updates. What is happening today? All recent biotech news and developments. Live coverage and timeline of biotech. All you need to know about biotech.
Genetic Technologies announces registered direct offering
Emyria to expand MDMA programs following TGA psychedelic decision ‘
Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC
AusBiotech responds to ³Ô¹ÏÍøÕ¾ Reconstruction Fund consultation
Keynote speaker announced for Women in Life Sciences Luncheon
GTG to form strategic alliance with global testing leader QIAGEN
Antisense Therapeutics announces outcomes in DMD combination animal study
AusBiotech strengthens Board with new appointments
Centenary Institute announces its new executive director
Emyria confirms first dosing for EMD-RX5 Phase 3 trial
AusBiotech advocates for sustainable funding model for TGA
FDA approves IND for Prader-Willi syndrome study of Neuren’s NNZ-2591
NSW launches Biosciences Fund to boost state’s world-class innovators
Chimeric Therapeutics updates on CLTX CAR T clinical trial
US recruitment milestone for trial of Immuron’s Travelan
AusBiotech’s draft ³Ô¹ÏÍøÕ¾ Reconstruction Fund submission open for comment
New Year’s resolutions for healthy future
Dimerix confirms the outcomes of a meeting with the FDA on paediatric plan for DMX-200
LBT Innovations subsidiary appoints APAS Independence distributor for Europe
Dimerix completes recruitment in first part of DMX-200 trial
Bionomics reports topline results in PREVAIL study of BNC210
AusBiotech office closure 20 December
Positive CHMP Opinion Etranacogene Dezaparvovec
ARCS Signature Program launched for senior leaders
Major industry award for Australian scientist at forefront of genetic breast cancer research
CSL announces appointment of its new CEO and managing director
CSL Announces Next CEO & Managing Director
CSL Closing of Arcturus Therapeutics Agreement
CSL’s Novel Gene Therapy HEMGENIX Demonstrates Durable Protection and Sustained Factor IX Activity Levels for People Living
Novotech awarded Asia Pacific CRO of Year 2022 for ‘Best Practices in Clinical Trials’
CSL opens its new ‘Australian Plasma Fractionation Facility’ in Melbourne
Nominations open for PM’s Prizes for Science
New Australian Plasma Fractionation Facility
Noxopharm provides update on trial of its oncology drug candidate
Vaxxas appoints Doug Cubbin as its new chief financial officer
Contributions now open for upcoming Australasian Biotechnology’
Pre-clinical data for Kazia Therapeutics’ EVT801 published in cancer journal
WEHI scientist recognised with CSL Florey Medal for malaria research
Developer announces plans for new medical research facility in Brisbane
³Ô¹ÏÍøÕ¾ Reconstruction Fund takes step forward
Immutep announces new collaboration for cancer treatment combination
Emyria accepted into US ³Ô¹ÏÍøÕ¾ Institutes of Health research program
Sonic Healthcare takes major strategic stake in Microba
Artificial intelligence high on life sciences’ agenda
Australian venture capital fund joins partners in backing new immunotherapy
CSL secures US approval for breakthrough one-time haemophilia gene therapy
AusBiotech gets behind campaign to combat ‘silent pandemic’
U.S. Food and Drug Administration approves CSL’s HEMGENIX , first gene therapy for hemophilia B

© 2024 - ³Ô¹ÏÍøÕ¾